Successively triggered Rod-shaped protocells for enhanced tumor Chemo-Photothermal therapy

Wei Zhang1, Lu Chen1, Mingshu Cui1

  • 1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Insights

Rod-shaped nanoparticles loaded with doxorubicin and indocyanine green effectively penetrate pancreatic tumors. This chemo-photothermal therapy enhances drug delivery and significantly reduces tumor volume in pancreatic ductal adenocarcinoma (PDAC) treatment.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Extracellular matrix hydrogels in solid tumors hinder therapeutic drug delivery.
  • Pancreatic ductal adenocarcinoma (PDAC) poses a significant public health challenge due to treatment limitations.

Purpose of the Study:

  • To design a novel nanoparticle for enhanced chemo-photothermal therapy in PDAC.
  • To improve drug penetration, cellular uptake, and targeted drug release for PDAC treatment.

Main Methods:

  • Development of rod-shaped protocell nanoparticles (RsPNs) loaded with doxorubicin hydrochloride (Dox) and indocyanine green (ICG).
  • Evaluation of nanoparticle penetration through matrix hydrogels and cellular uptake via caveolin-mediated endocytosis.
  • Assessment of photothermal effect and hyperthermia-triggered drug release under laser irradiation.
  • Pharmacodynamic studies to evaluate tumor volume reduction.

Main Results:

  • Rod-shaped RsPNs demonstrated enhanced penetration of matrix hydrogels and significant tumor accumulation.
  • Dox/ICG-RsPNs were effectively internalized by BxPC-3 cells.
  • Indocyanine green (ICG) provided a photothermal conversion efficiency of 16.2%, facilitating hyperthermia-induced Dox release to the nucleus.
  • Significant reduction in relative tumor volume (1.37) was observed with Dox/ICG-RsPNs under irradiation compared to control groups.

Conclusions:

  • The designed Dox/ICG-RsPNs show promise for overcoming extracellular matrix barriers in PDAC.
  • This chemo-photothermal strategy offers an effective approach for targeted drug delivery and combination therapy in PDAC.
  • Rational design of such drug delivery systems can significantly improve therapeutic outcomes for PDAC.

Related Concept Videos